newsfilter
← Latest News
GlobeNewswire·

AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022

PHILADELPHIA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ:ANPC), a biotechnology company with operations in China and the United States, announced